FindTrial
Sign In

Pregnancy outcome in WHO partogram and paperless partogram

Pregnancy outcome in WHO Partogram and paperless partogram :single blinded randomised control trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2021/01/030214
Enrollment
118
Registered
2021-01-04
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: - Health Condition 2: - Health Condition 3: O620- Primary inadequate contractions

Interventions

Intervention1: Pregnancy outcome in WHO Partogram and paperless partogram : single blinded randomised control trial: Women in spontaneous labour are alloted either WHO partogram or paperless partogram

Sponsors

Veer surendra sai institute of medical sciences and research
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Antenatal women ( primigravida) with 36 to 42 completed week of pregnancy Singleton pregnancy with cephalic presentation Patient must be atleast 4cm or more dilated at the point of inclusion

Exclusion criteria

Exclusion criteria: Known case of major fetal structural anomaly Women with history of previous uterine surgery Women with acute obstetrical complications like APH ECLAMPSIA Cephalopelvic dispropertion Active HSV infection PLHA Hbs antigen postive Genital warts ANC with other comorbidities like heart disease liver disease kidney disease

Design outcomes

Primary

MeasureTime frame
Incidence of augmentation (oxytocin induction or Artificial rupture of membranes Incidence of plain IV drip used in active phase No Of er vaginal examination during active phase Total duration of labor -upto the birth of baby Nature of delivery (VD /LSCS/INSTRUMENTAL) Incidence of PPHTimepoint: At baseline and duruing active labor. Incidence of augmentation (oxytocin induction or Artificial rupture of membranes after action ETD Incidence of plain IV drip used in active phase No Of vaginal examination during active phase Total duration of labor -upto the birth of baby Nature of delivery (VD /LSCS/INSTRUMENTAL) AFTER ACTION ETD Incidence of PPH—

Secondary

MeasureTime frame
APGAR of newborn at 1st and 5th min of birth Neonatal outcomes (good/ SNCU)Timepoint: Apgar at 1st and 5th min of birth of newborn Neonatal outcomes (good / outcomes) at baseline—

Countries

India

Contacts

Public ContactDr Debasmita padhy

Veer Surendra Sai institute of medical sciences and research

santoshdora1@gmail.com7978279890

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026